Other Events ·
bioAffinity Technologies, Inc. received a notice from Nasdaq on July 30, 2026, indicating non-compliance with the…
BIAFWbioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. received a notice from Nasdaq on July 30, 2026, indicating non-compliance with the minimum bid price requirement due to its common stock closing below $1.00 for thirty consecutive business days ending July 29, 2026. The company is ineligible for the standard 180-day cure period because it executed a 1-for-30 reverse stock split on September 19, 2025. bioAffinity intends to appeal this determination on August 6, 2026, which will stay any delisting or suspension pending the Panel's decision. The company operates in the biotechnology industry.